journal article·2025-07Open access

PHOSPHO1 Suppresses Ferroptosis in Retinal Pigment Epithelial Cells by Reducing the Levels of Phosphatidylethanolamine Molecular Species

Zhiyang Chen, Xiaoman Zhu, Michael Mingze Lu, Qingjian Ou, Xueying Wang, Zhenzhen Zhao, Qi Shen, Qian Wang, Zhe Wang, Jing‐Ying Xu, Caixia Jin, Furong Gao, Juan Wang, Jingfa Zhang, Jieping Zhang, Xiaoliang Jin, Yanlong Bi, Lixia Lu, Guo‐Tong Xu, Haibin Tian

Advanced Science· Volume 12· Issue 28

Abstract

Abstract Iron‐induced lipid peroxidation of phosphatidylethanolamine (PE) species is a key driver of ferroptosis in retinal pigment epithelial (RPE) cells, a process closely associated with age‐related macular degeneration (AMD). The previous studies have demonstrated that induced retinal pigment epithelial (iRPE) cells generated by transcription factor‐mediated reprogramming exhibit superior therapeutic efficacy in treating AMD. In this study, it is found that these iRPE cells are resistant to ferroptosis and further identified phosphoethanolamine/phosphocholine phosphatase 1 (PHOSPHO1) as a critical regulator underlying ferroptosis resistance. Mechanistically, PHOSPHO1 inhibits ferroptosis through two distinct mechanisms. First, it reduces PE levels in the endoplasmic reticulum, thereby limiting PE‐derived lipid peroxidation. Second, it suppresses autophagy and ferritinophagy, leading to a reduction in intracellular free iron accumulation. Experiments using an in vivo rat model confirm that PHOSPHO1 effectively protects RPE cells from ferroptotic damage. These findings highlight PHOSPHO1 as a potential therapeutic target for AMD, providing insights into novel ferroptosis‐based intervention strategies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Autophagy in Disease and Therapy · Ferroptosis and cancer prognosis · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute School of Medicine Tongji University Shanghai 200065 China

Department of Physiology and Pharmacology School of Medicine Tongji University Shanghai 200092 China

Department of Physiology College of Basic Medical Sciences Naval Medical University Shanghai 200433 China

The International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen) Shenzhen 518000 China

Department of Ophthalmology Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

Funding

Ministry of Science and Technology of the People's Republic of China · Natural Science Foundation of Shanghai Municipality · Shanghai Municipal Health Commission · National Natural Science Foundation of China

References (59)

Show source-provided references
1. 10.1016/j.exer.2016.08.00810.1016/j.exer.2016.08.008 ↗
2. 10.1016/j.redox.2021.10197110.1016/j.redox.2021.101971 ↗
3. 10.14336/AD.2020.091210.14336/AD.2020.0912 ↗
4. 10.1016/j.exer.2015.05.01910.1016/j.exer.2015.05.019 ↗
5. 10.1016/j.freeradbiomed.2018.09.00810.1016/j.freeradbiomed.2018.09.008 ↗
6. 10.1155/2022/179289410.1155/2022/1792894 ↗
7. 10.1016/j.freeradbiomed.2012.04.02010.1016/j.freeradbiomed.2012.04.020 ↗
8. 10.1016/j.bbrc.2021.02.05510.1016/j.bbrc.2021.02.055 ↗
9. 10.1089/jop.2014.007410.1089/jop.2014.0074 ↗
10. 10.1038/s41392-020-00428-910.1038/s41392-020-00428-9 ↗
11. 10.3389/fcell.2021.63985110.3389/fcell.2021.639851 ↗
12. Liu Z. · Free Radicals Biol. · 2024
13. 10.1038/nchembio.223810.1038/nchembio.2238 ↗
14. 10.1097/CCM.000000000000355510.1097/CCM.0000000000003555 ↗
15. 10.1038/s41419-018-0794-410.1038/s41419-018-0794-4 ↗
16. 10.1080/15548627.2016.118736610.1080/15548627.2016.1187366 ↗
17. 10.1146/annurev-cellbio-092910-15400510.1146/annurev-cellbio-092910-154005 ↗
18. 10.1016/j.isci.2022.10505010.1016/j.isci.2022.105050 ↗
19. 10.1016/j.redox.2020.10169710.1016/j.redox.2020.101697 ↗
20. 10.7150/ijms.5486010.7150/ijms.54860 ↗
21. 10.1021/acschembio.8b0019910.1021/acschembio.8b00199 ↗
22. 10.1016/S0021-9258(19)41523-810.1016/S0021-9258(19)41523-8 ↗
23. 10.1074/jbc.M113.48923710.1074/jbc.M113.489237 ↗
24. 10.1104/pp.19.0139910.1104/pp.19.01399 ↗
25. 10.1016/bs.ircmb.2015.10.00110.1016/bs.ircmb.2015.10.001 ↗
26. 10.1186/gm31510.1186/gm315 ↗
27. 10.1002/jbmr.479610.1002/jbmr.4796 ↗
28. 10.1530/JOE-19-046010.1530/JOE-19-0460 ↗
29. 10.1016/j.redox.2022.10229210.1016/j.redox.2022.102292 ↗
30. 10.1038/s41589-020-0472-610.1038/s41589-020-0472-6 ↗
31. 10.1021/acschembio.2c0031710.1021/acschembio.2c00317 ↗
32. 10.1042/BJ2004051110.1042/BJ20040511 ↗
33. 10.1038/s41419-023-05978-810.1038/s41419-023-05978-8 ↗
34. 10.1007/978-1-59745-157-4_410.1007/978-1-59745-157-4_4 ↗
35. 10.1007/978-3-030-62026-4_410.1007/978-3-030-62026-4_4 ↗
36. Wang C. · Liver · 2023
37. 10.1111/acel.1349010.1111/acel.13490 ↗
38. 10.1016/j.bbrc.2016.10.08610.1016/j.bbrc.2016.10.086 ↗
39. 10.1038/s41598-018-23408-010.1038/s41598-018-23408-0 ↗
40. 10.3390/biology908018710.3390/biology9080187 ↗
41. 10.1016/0005-2760(82)90093-510.1016/0005-2760(82)90093-5 ↗
42. 10.1167/iovs.64.14.1010.1167/iovs.64.14.10 ↗
43. 10.1038/nm170910.1038/nm1709 ↗
44. 10.1016/j.exer.2018.09.01210.1016/j.exer.2018.09.012 ↗
45. 10.4161/auto.2678710.4161/auto.26787 ↗
46. 10.1083/jcb.20080313710.1083/jcb.200803137 ↗
47. 10.1001/archopht.121.8.109910.1001/archopht.121.8.1099 ↗
48. 10.1016/j.intimp.2024.11304110.1016/j.intimp.2024.113041 ↗
49. Wang L. · Curr. Mol. Med. · 2017 · 17 · 421
50. 10.4161/auto.3618410.4161/auto.36184 ↗
51. 10.1074/jbc.M115.68231010.1074/jbc.M115.682310 ↗
52. 10.1530/JOE-22-009710.1530/JOE-22-0097 ↗
53. 10.1182/blood-2018-03-83851610.1182/blood-2018-03-838516 ↗
54. 10.1007/s11596-022-2612-610.1007/s11596-022-2612-6 ↗
55. 10.1002/j.1460-2075.1993.tb05839.x10.1002/j.1460-2075.1993.tb05839.x ↗
56. 10.1016/j.bbrc.2005.03.01210.1016/j.bbrc.2005.03.012 ↗
57. 10.3390/ijms2119699310.3390/ijms21196993 ↗
58. 10.3390/diagnostics1407076410.3390/diagnostics14070764 ↗
59. 10.1038/s41419-022-05199-510.1038/s41419-022-05199-5 ↗